Nesprin interchain associations control nuclear size
- First Online:
- Cite this article as:
- Lu, W., Schneider, M., Neumann, S. et al. Cell. Mol. Life Sci. (2012) 69: 3493. doi:10.1007/s00018-012-1034-1
Nesprins-1/-2/-3/-4 are nuclear envelope proteins, which connect nuclei to the cytoskeleton. The largest nesprin-1/-2 isoforms (termed giant) tether F-actin through their N-terminal actin binding domain (ABD). Nesprin-3, however, lacks an ABD and associates instead to plectin, which binds intermediate filaments. Nesprins are integrated into the outer nuclear membrane via their C-terminal KASH-domain. Here, we show that nesprin-1/-2 ABDs physically and functionally interact with nesprin-3. Thus, both ends of nesprin-1/-2 giant are integrated at the nuclear surface: via the C-terminal KASH-domain and the N-terminal ABD-nesprin-3 association. Interestingly, nesprin-2 ABD or KASH-domain overexpression leads to increased nuclear areas. Conversely, nesprin-2 mini (contains the ABD and KASH-domain but lacks the massive nesprin-2 giant rod segment) expression yields smaller nuclei. Nuclear shrinkage is further enhanced upon nesprin-3 co-expression or microfilament depolymerization. Our findings suggest that multivariate intermolecular nesprin interactions with the cytoskeleton form a lattice-like filamentous network covering the outer nuclear membrane, which determines nuclear size.
KeywordsActin binding domain Cytoskeleton KASH-domain LINC complex Nesprin Nuclear envelope Nuclear shape SUN-domain
Actin binding domain
Green fluorescent protein
Klarsicht, ANC-1, and Syne Homology
Inner nuclear membrane
Linker of the nucleoskeleton and cytoskeleton
Nuclear envelope spectrin repeat protein
Outer nuclear membrane
Small interfering RNA
Sad1 and UNC-84
The nuclear envelope (NE) is the defining feature of all eukaryotes, which separates the nucleoplasm from the cytoplasm. It is composed of two structurally distinct and concentric lipid bilayers, the inner and outer nuclear membranes (INM and ONM). These are separated by the perinuclear space (PNS), connected at nuclear pore complexes (NPCs) and bridged by specific ONM–INM protein assemblies (termed the LINC complex), that connect cytoplasmic structures with the nuclear interior [1–3]. The ONM is contiguous with the rough endoplasmic reticulum (ER), while the INM contains distinct membrane proteins, which form close associations with the underlying chromatin and nuclear lamina. The lamina provides a structural scaffold to the NE and is composed primarily of nuclear intermediate filament proteins, the lamins [4–7].
LINC complex components have been found in a wide array of organisms that include plants, yeast, amoebae, worms, flies, and vertebrates [8–13]. The complex is composed of the ONM-resident KASH (Klarsicht, ANC-1, and Syne Homology) and the INM-targeted SUN (Sad1 and UNC-84) domain proteins. The C-terminal KASH-domain encompasses a single transmembrane segment, which is followed by an evolutionarily conserved PNS-situated short peptide that associates directly with SUN protein luminal domains [14–19]. Mammalian SUN-domain proteins form stable oligomeric assemblies and are essential for KASH-domain protein recruitment to the ONM [14, 20]. In contrast to their highly conserved C-termini, KASH protein N-terminal segments are divergent. There is considerable variation in length, due to differing spectrin repeat (SR) copy numbers. They also contain specific domains, which interact with different proteins, enabling the integration of the ONM with various cytoskeletal structures [12, 21, 22].
To date, four proteins with KASH-domains and SRs have been identified in mammals, termed nesprins-1/-2/-3/-4. Each nesprin is encoded by a separate gene that gives rise to a multitude of structurally and functionally diverse isoforms [23–27]. The largest gene products of the syne-1/-2 loci are referred to as nesprins-1/-2 giant (alternatively known as NUANCE and Enaptin, respectively). These macromolecules (>800 kDa) comprise an N-terminal actin binding domain (ABD), which is separated from the C-terminal nuclear membrane integration site by a massive SR rod segment [24, 25]. In contrast, nesprin-3 and -4 proteins are much smaller (<116 kDa) and lack an ABD. It is noteworthy, however, that nesprin-3 possesses an N-terminal binding site for the plectin ABD, which is a versatile cytolinker that crossbridges all major cytoskeletal elements including intermediate filaments [26, 28]. Moreover, the tissue-specific nesprin-4 associates to the plus-end microtubule motor kinesin-1 and contributes to cellular polarization . Thus, nesprins are key and versatile determinants of the ONM cytoskeletal landscapes, which define cellular architecture and cell behavior. These molecules endow the mammalian cell with a diverse repertoire of fundamental biological functions. Nesprins have roles in the control of cellular stiffness, ciliogenesis, organelle positioning (e.g., nucleus, Golgi, centrosome), endocytosis, Wnt-signaling, directed cellular migration, and cell adhesion [12, 22, 29–38].
Human and murine genetic studies further underline their biological significance and functional diversity at the organismal level. Nesprin-1 and -2 defects have been linked to human diseases including: muscular dystrophy, arthrogryposis, ataxia, progeria, lissencephaly, and cancer [39–46]. Nesprin-1/-2 KASH-domain double knockout mice die shortly after birth due to respiratory failure . However, single nesprin-1 C-terminal knockouts vary in their phenotypes depending on which exons are deleted. Overall, nesprin-1 mouse mutants exhibit decreased survival rates, severe growth retardation, kyphoscoliosis, neurogenesis defects, and skeletal/cardiac muscle pathologies [31, 47, 48]. In contrast, nesprin-2 KASH-domain knockout mice are viable, but display severe learning and memory deficits . Similarly, nesprin-2 giant-deficient mice are also viable and do not exhibit any gross physical abnormalities. However, the loss of nesprin-2 giant impairs NE architecture morphology and composition [32, 41]. As a consequence, nuclei become irregularly shaped and enlarged, which contributes to a mild increase in epidermal thickness . How nesprin-2 giant controls nuclear shape remains largely unresolved. Current models depict the giant nesprin-1/-2 KASH-domain isoforms as radiating ONM molecules projecting into the cytoplasm. These massive molecules are conceived as flexible spokes that function as the suspension apparatus of the nucleus rather than rigid molecules that encase the nuclear exterior. Clearly, the former arrangement does not accommodate well the structural defects that occur when these massive proteins are missing [32, 42]. More importantly, all currently available models are speculative and have not been experimentally validated.
In the current paper, we provide compelling evidence that nesprin-1/-2 giant proteins are integrated at the NE, at both ends of the molecules. While the KASH-domain embeds the C-terminus directly into the ONM, molecular interactions that involve nesprin-3 and the nesprin-1/-2 N-termini may account for their alignment along the nuclear surface. In agreement with this model, interference with nesprin-2 giant N- or C-terminal domain binding results in nuclear expansion. Conversely, the co-expression of nesprin-3 and nesprin-2 fusions, that lack the massive central rod domain of nesprin-2 giant, triggers nuclear shrinkage. Taken together, these data suggest the presence of a filamentous nesprin-based meshwork, which structurally supports and links the outer nuclear surface to its cellular surrounding.
Materials and methods
Cloning strategies and siRNA approaches
GFP-Nesprin-1 ABD (aa 2–296) and GFP-Enaptin-165 (aa 1–1,431) are described elsewhere . GFP-Nesprin-2 KASH is equivalent to TmNesprin-2 (aa 6,835–6,885) . GFP-Nesprin-2 ABD (aa 1–285) and GFP-Nesprin-2 mini (aa 1–459, 6,644–6,885) are equal to GFP-ABD and GFP-NUA∆460–6,643, respectively . Nesprin-2 SR-KASH was amplified via RT-PCR from HaCaT cDNA and ligated into the EcoRI/SalI cloning site of EGFP-C2. Nesprin-2 SR-KASH equals the aa 6,147–6,885 sequence of Nesprin-2 giant, except that it contains a 23 aa insertion (DVEIPENPEAYLKMTTKTLKASS, which corresponds to an alternative spliced exon) after aa 6,444. Human Nesprin-3 full-length (FL) (aa 1–975; cDNA inserted into the KpnI/NotI cloning site of pCMV-HA, or into the KpnI/NotI cloning site of pCMV-Myc); Nesprin-3 ΔC (aa 1–441; inserted into the AhdI/SacII cloning site of EGFP-C2); Nesprin-3 KASH (aa 924–975; inserted into the KpnI/NotI cloning site of pCMV-Myc); Nesprin-3 SR1, Nesprin-3 SR2, Nesprin-3 SR1,2 and Nesprin-3 SR1,2,3 (aa 1–106, aa 104–228, aa 1–228 and aa 1–325, respectively; cloned into EcoRI/SalI digested pGEX4T1) were constructed by PCR using the AK098471 and AK131436 cDNAs (Department of Biotechnology, Japan, http://www.nbrc.nite.go.jp) as templates. GFP-Plectin-1c ABD was kindly provided by Dr. Arto Maatta.
siRNA experiments were performed according to the manufacturer’s instructions (Qiagen). The following siRNAs were used: FlexiTube Hs_PLEC_7 targeting the human plectin sequence 5′-CAAGGTGTACCGGCAGACCAA-3′ and AllStars negative control duplexes (all from Qiagen). In brief, cells were allowed to recover for 2 days after the first siRNA treatment, before they were subjected to a second round of siRNA tranfection. The following day, cells were seeded on glass cover slips, fixed with methanol the next day and processed for immunofluorescence staining.
Cell culture, cytoskeleton pharmacological treatments and transfections
COS7, human keratinocyte (HaCaT) and human primary fibroblasts were grown at 37 °C, 5 % CO2 in high glucose DMEM (Sigma-Aldrich) supplemented with 2 mM glutamine, 1 % penicillin/streptomycin and 10 % FBS.
COS7 cells were transiently transfected at 170 V, 950 μF by electroporation using a Gene-Pulser (Bio-Rad). For transient transfections of the HaCaT cell line, the Amaxa Cell Line Nucleofector Kit V (Lonza) was utilized. Transfected cells were grown for 24–48 h before fixation. To depolymerize F-actin, cells were treated with latrunculin B (1 μg/ml; Sigma-Aldrich) for 30 min (COS7 cells) or 60 min (HaCaT cells), before fixation. To depolymerize microtubules, cells were treated with 12 μM colchicine (Sigma-Aldrich) for 60 min before fixation.
Antibodies and immunofluorescence (IF) microscopy
Cells grown on cover slips were fixed in 4 % paraformaldehyde in phosphate-buffered saline (PBS) for 10 min followed by permeabilization with 0.5 % Triton X-100 for 5 min. Alternatively, cells were fixed in cold methanol (−20ºC) for 10 min. Fixed samples were blocked in phosphate-buffered gelatine (PBG; contains 0.1 % cold water fish-gelatine and 0.5 % BSA) for 15 min and incubated with primary antibodies (diluted in PBG) for 60 min at room temperature. The following antibodies were used: GFP-specific mAb K3-184-2 , mouse anti-myc , mouse anti-cytokeratin (AE1/AE3; Millipore), mouse anti-β-actin (AC-74; Sigma-Aldrich), mouse anti-tubulin (WA3; kind gift of Dr. U. Euteneuer), mouse anti-vinculin (hVIN-1; Sigma-Aldrich), rabbit anti-GST , rat anti-HA (3F10; Santa Cruz Biotechnology), goat anti-plectin (C-20; Santa Cruz Biotechnology), rabbit anti-plectin (Abcam), mouse monoclonal anti-nesprin-3 (kind gift of Dr. A. Sonnenberg; ), mouse anti-nes2NT (mAb K20; ), affinity-purified rabbit anti-nes2CT (pAb K1; ), and rabbit anti-nes1NT and anti-nes1CT . Cells were extensively washed in PBS and then incubated with the relevant secondary antibodies, which were conjugated with Cy5 (Sigma-Aldrich), Alexa Fluor 488, Alexa Fluor 568, or Alexa Fluor 647 (Invitrogen). PBS-washed specimens were then mounted in Gelvatol/DABCO (Sigma-Aldrich). F-actin was visualized by TRITC-labelled phalloidin (Sigma-Aldrich) and DNA was counterstained with 4′,6-diamino-2-phenylindone (DAPI; Sigma-Aldrich). All samples were analyzed by confocal laser-scanning microscopy using either a TCS-SP1/SP5 (Leica) or a LSM510-Meta (Zeiss).
Purification of GST fusion proteins, GST pull-down, His pull-down assays, western blotting and immunoprecipitation
GST-fusion proteins (GST-nes-3 SR1, GST-nes-3 SR2, GST-nes-3 SR1,2, and GST-nes-3 SR1,2,3 fusions, respectively) were bound to Glutathione-SepharoseTM 4B (Amersham) at 4 °C overnight. GFP-nes-1 ABD, GFP-nes-2 ABD, or GFP-plectin-1c ABD transfected COS7 cell lysates were generated using lysis buffer (50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1 % Nonidet P-40, 0.5 % sodium deoxycholate and protease inhibitors; Roche). The lysates were then incubated with equal quantities of GST-fusion proteins coupled to GST-Sepharose beads at 4 °C overnight. Samples were centrifuged and pellets were extensively washed with PBS. Supernatant and pellet samples were assessed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) concomitant by Coomassie Blue staining and western blot analysis . For His pull-down assays, E. coli expressed His-nesprin-1 ABD and His-nesprin-2 ABD were coupled to Ni–NTA agarose beads by incubation for 4 h at 4 °C as described in the manufacturer’s manual (Qiagen). GFP or GFP-nesprin-3 ΔC transfected COS7 lysates were incubated with beads coupled with His-fusions at 4 °C overnight. The pellets were washed with PBS and analyzed by western blot. For immunoprecipitation analysis, myc-nesprin-3 full-length transfected COS7 cells were lysed in buffer containing 50 mM Tris–HCl, pH 7.5, 150 mM NaCl, and 0.5 % Nonidet P-40, and the immunoprecipication was performed as described .
F-actin binding assays
Purified skeletal muscle actin (Cytoskeleton, #AKL99) was resuspended in G-buffer (0.2 mM CaCl2, 0.2 mM ATP, 0.5 mM DTT, 5 mM Tris, pH 8.0), incubated for 1 h on ice and subjected to centrifugation at 30,000g for 15 min at 4 °C, to remove actin polymers. His-tagged nes-2 ABD was purified as described above, concentrated using Pierce protein concentrators (20K MWCO; Thermo Scientific), and dialyzed overnight at 4 °C in P-buffer (2 mM MgCl2, 50 mM KCl, 1 mM ATP, 0.5 mM DTT, 5 mM Tris, pH 8.0) containing protease inhibitors. Glutathione–Sepharose coupled GST-nes-3 SR1,2,3 or GST proteins were incubated with His-tagged nes-2 ABD in the absence or presence of actin for 1 h at room temperature, under conditions that induce F-actin polymerization (usage of P-buffer). The samples were centrifuged at 1,000g for 2 min and the pellets (PD: pull-down) were prepared for SDS-PAGE analysis while the supernatants were ultra-centrifuged at 100,000g for 60 min at 4 °C. The resulting supernatants (S) and pellets (P) were mixed with Laemmli sample buffer and resolved by SDS-PAGE together with the PD samples and then stained by Coomassie Blue to visualize the proteins.
Statistical and morphometric analysis
Statistical analysis was performed using Student’s t test, and data are shown as mean (%) ± SD (standard deviation) unless otherwise stated. P values ≤ 0.05 (denoted with *; decimal decrements indicated by the addition of further *) were considered significant.
HaCaT cells (2 days post-transfection) were imaged using a Leica SP5 confocal microscope. The mean nuclear area of transfected cells was measured (largest cross-sectional nuclear area) using the software Image J, and normalized by the mean nuclear area of untransfected HaCaT cells (200 cells computed for each experiment; except for the SR-KASH and SR-KASH and nes-3 FL transfections where at least 60 nuclei were analyzed; Fig. 7f). Alternatively, mock and GFP-fusion transfected HaCaT cells were subjected (either directly or incubated for 1 h with cytoskeleton depolymerizing drugs prior fixation) to immunofluorescence and DAPI staining 2 days after transfection and imaged using an Axioskop 40 Zeiss epifluorescence microscope. Images were recorded with an AxioCam MRM (Zeiss) and the cell (200 phalloidin-stained cells counted for each condition; Fig. 7g) and nuclear area (100 cells counted for each condition; Fig. 8e) were calculated using the AxioVision v.4.5 software (Zeiss). All cells were plated at identical cell densities and only transfected cells situated at the periphery of small colonies (2–8 cells) were measured.
Nesprin-3 full-length proteins display reduced dominant negative properties compared to nesprin-3 KASH-domain fusions
To gain insights into the NE targeting mechanisms of nesprins, we examined the KASH-domain localization properties of the widely expressed nesprin-1/-2/-3 paralogues. We did not include nesprin-4, because of its confined expression in secretory epithelial cells. Since nesprins-1/-2 are differentially expressed, HaCaT and COS7 are our preferred cellular models for nesprin-2 studies, while fibroblasts are employed to investigate NE-associated nesprin-1 isoforms.
Ectopically expressed nesprin-3 recruits the nesprin-2 ABD, which in turn recruits F-actin
Similar to HaCaT cells (Fig. 1e), ectopically expressed nes-3 FL accumulated prominently at the nuclear rim of COS7 transfected cells (Fig. 2c, d). The overexpression of nesprin-3α alone did not trigger significant F-actin recruitment around the nucleus (Fig. 2c). When GFP-nes-2 ABD was co-expressed with nes-3 FL, it resulted in a dramatic accumulation of nes-2 ABD at the nuclear surface (Fig. 2d′, d′′, arrow) in 82 % of transfectants (Fig. 2g). Interestingly, the accumulation of nes-2 ABD at the NE coincided now with prominent peri-nuclear F-actin structures (Fig. 2e-e′′′). Since nesprin-3 has the ability to redistribute plectin , which is an F-actin binding protein, the nesprin-2 ABD relocation may have emerged as the result of plectin-mediated recruitment of ABD-decorated actin structures to the nuclear rim, as opposed to direct associations between nesprins-2 and -3. To investigate this caveat, we treated cells that were co-expressing nesprin-2 ABD and nesprin-3 with latrunculin B, which prevents actin polymerization. Similar to untreated cells, nesprin-3 still recruited the nesprin-2 ABD to the NE while F-actin was absent (Fig. 2f-f′′′). Thus, the nesprin-3 induced recruitment of the nesprin-2 ABD is not mediated via F-actin.
Nesprin-3 associates in vitro with the nesprin-1/-2 ABDs
We next examined biochemically the association of nesprin-3 with the nesprin-1 and nesprin-2 ABDs using His-tagged protein pull-down assays. We also included the nesprin-1 ABD in our analysis (nes-1 ABD; Fig. S1) because of its high primary sequence identity to nesprin-2 (53.49 %; Fig. S3), which suggested that nesprin-1 and -2 ABDs may display similar biochemical properties with respect to nesprin-3. For this analysis, we used nesprin-3 ΔC, which is a C-terminal truncated construct, that harbors only the first four nesprin-3α spectrin repeats (SR) and which lacks the KASH-domain (see Fig. S1 for structural details). Although only the first nesprin-3 SR is required for plectin binding, we decided to employ a longer nesprin-3 SR fusion (nesprin-3 ΔC) in order to facilitate proper SR folding. As anticipated, both His-tagged nesprin-1 and nesprin-2 recombinant ABDs specifically precipitated GFP-tagged nesprin-3 ΔC and not GFP alone (Fig. 2h). Overall, these results show that nesprin-3 can specifically interact with the ABDs of nesprins-1 and -2.
Nesprin-3 recruits nesprin-1 ABD-containing isoforms to the NE
To allow further insights into the nesprin-3 mediated recruitment mechanism, we analyzed COS7 cells, which enable high transfection rates, and looked at the subcellular distribution of ectopically expressed GFP-tagged Enaptin-165, an N-terminal ABD-containing isoform of nesprin-1 (Fig. S1). As previously reported , when GFP-Enaptin-165 alone was ectopically expressed, it localized to F-actin rich structures (e.g., cortical regions and stress-fibres) (Fig. 3c-c′, arrowheads). In addition, weak Enaptin-165 NE staining was evident in 36 % of transfected cells (Fig. 3f). Similar to endogenous nesprin-1, Enaptin-165 also redistributed to the NE upon nesprin-3 expression (Fig. 3d-d′, arrows). Specifically, NE enrichment was observed in 71.5 % of HA-tagged nes-3 FL and GFP-Enaptin-165 co-transfected cells (Fig. 3f). Collectively, this illustrates that nesprin-3 is able to recruit nesprin-1 ABD-containing isoforms to the NE.
The nesprin-2 ABD interacts directly with nesprin-3 in the presence of F-actin
The molecular mechanisms by which plectin and nesprin-1/-2 ABDs associate to nesprin-3 are not identical
Although we were unsuccessful in further narrowing the respective binding domains, our data suggested the testable possibility that nesprin-3 may be able to simultaneously bind to plectin and to either nesprin-1 or nesprin-2 as a direct consequence of harboring differential binding sites to these molecules.
Nesprin-3 does simultaneously recruit both the nesprin-2 ABD and plectin to the NE
Next, we explored whether the nesprin-3 mediated redistribution of the nesprin-2 ABD requires plectin. To address this caveat, we examined the subcellular ABD pattern in control (Fig. 6f) and plectin siRNA treated (Fig. 6g–g′′) COS7 cells. The efficacy of our silencing strategy was evaluated in anti-plectin immunoblot experiments, which demonstrated a significant plectin downregulation (Fig. 6e). In control silenced cells, both nesprin-2 ABD and plectin staining revealed pronounced cytoplasmic filamentous structures (Fig. 6f) with no obvious NE localization, as in untransfected controls (Fig. 6a). When plectin is downregulated, and nesprin-3 FL ectopically expressed (Fig. 6g′), the nesprin-2 ABD again became prevalent at the NE (Fig. 6g), although plectin was largely undetectable (Fig. 6g′′). Our data suggest that the nesprin-3 interaction with nesprin-2 is plectin independent.
Nesprin-2 and nesprin-3 associations control the nuclear morphology of HaCaT cells
Since nuclear and cell size are tightly coupled and regulated [32, 53] (Fig. S5A–A′), we next examined whether nesprin-2-derived domain overexpression also modulates the shape of transfected cells. Cell morphologies were visualized by phalloidin counter-staining (Fig. S5). Quantitative analysis indicated indeed significant cell shape changes upon nesprin-2 transgene expression (Fig. 7g; Fig. S5). Specifically, the area of control HaCaT cells (1,033.7 ± 370 μm2) became enlarged upon nesprin-2 ABD (1,119.3 ± 320 μm2) or KASH-domain (1,210 ± 332 μm2) overexpression, while nesprin-2 mini positive cells exhibited smaller cell areas (787 ± 235 μm2) (Fig. 7g). These data indicate that nesprin-2-mediated nuclear shape changes are accompanied by analogous cellular changes, which is in agreement with previously published work . Interestingly, however, while cell spreading was modulated, the expression levels of key cytoskeleton proteins, cell-substratum (vinculin), and cell–cell (E-cadherin; data not shown) adhesion molecules remained unchanged (Fig. 7h). In summary, our data identify the nesprin-2 giant N-terminus and in particular the ABD as a pivotal structure that modulates both nuclear and cellular architecture.
Nesprin-2 mini and cytoskeleton-mediated tensions regulate nuclear size
Nesprins control fundamental aspects of the cell such as architecture, asymmetry, stiffness and even signaling [12, 22, 38, 54]. How these molecules master all these multiple functions is poorly understood. In this paper, we highlight the structural nesprin-1/-2 giant molecule features by providing novel insights into their associations with nesprin-3 and by discussing their possible arrangement at the NE.
The first nesprin-3α spectrin repeat (SR1; plakin-binding domain) was already known to associate with the ABDs of the cytoskeletal linker proteins plectin and MACF1 . Here, we further expand the nesprin-3 complex repertoire by revealing novel associations with the nesprin-1/-2 ABDs both in vitro and in vivo. Our studies, however, identify differences between the implicated domains of nesprin-3. More specifically, our data show that, in contrast to plectin, nesprin-1/-2 ABDs interact weakly with nesprin-3 SR1. Only the use of larger nesprin-3 fusions, that contain in addition the second spectrin repeat (SR2), increases its affinity to the ABDs. This result suggests that either nesprin-3 contains multiple nesprin-1/-2 ABD binding sites or that SR2 allows proper SR1 folding and thereby increases its affinity to nesprin-1/-2. We cannot exclude the latter, but do favor the former scenario. This interpretation is based on the presence of both plectin and nesprin-2 giant in the nesprin-3 immunoprecipitates. Furthermore, the nesprin-3-mediated recruitment of nesprin-2 ABD coincided with the repositioning of plectin to the NE in transfected cells. Thus, tripartite nesprin-2/nesprin-3 and plectin complexes can be formed. Importantly, we also showed that the capacity of nesprin-3 to associate with the nesprin-2 ABD does not compromise their ability to recruit F-actin. Collectively, this indicates that nesprin-3 may integrate not only intermediate filaments but also F-actin (via nesprins-1/-2 giant) at the nuclear surface.
While we do not underestimate the biological significance of versatile cytoskeletal nesprin-3 attachment sites, we are particularly intrigued by the physical consequences of nesprin-3 binding on the arrangement of the nesprin-1/-2 giant molecules at the NE. By capturing the N-terminal ends of these massive proteins, nesprin-3 would in principle align them along the ONM. Such a model is not consistent with current schematics depicting the giant nesprin molecules as radiating filaments projecting into the cytoplasm. However, several lines of evidence support the novel model that we propose here. Firstly, massive proteins usually have differential immunofluorescence patterns of their N- and C-terminal epitopes. For instance, the nebulin C-terminus (600–900 kDa) localizes at Z-discs, while its N-terminus is distinctively positioned towards the sarcomere centre . Importantly, however, the nesprin-2 giant staining pattern using antibodies directed against the ABD and its C-terminal domain is largely identical . This finding suggests that the nesprin-2 giant N-terminus is positioned near the nuclear membrane and close to the C-terminus of another nesprin-2 molecule. Secondly, most spectrin-containing molecules are aligned along membrane surfaces and do not protrude into the cytoplasm. In red blood cells, spectrin lines the intracellular side of the plasma membrane forming a filamentous network. This two-dimensional spectrin meshwork provides a scaffold for a variety of proteins and plays important roles in cell shape maintenance . Studies on isolated membranes and phospholipid vesicles also indicate bilayer lamination by spectrin dimers . Dystrophin, another spectrin-containing protein is also suspected to align the plasma membrane and to create a link between the intracellular cytoskeleton and the extracellular matrix via the dystrophin-associated protein complex in muscle [58–61]. Finally, the strongest evidence that giant nesprin molecules line the outer NE surface comes from our studies that reveal important roles in nuclear shape control. The interference with the nesprin-2 giant molecule ends triggers nuclear enlargement, whereas the overexpression of nesprin-2 mini leads to nuclear compaction. Our hypothesis is that nesprin-2 mini dislodges endogenous giant isoforms from the NE and that its presence tightens (as a consequence of its drastically shorter rod domain) the nesprin-1/-2/-3 “belt” that would normally encapsulate the NE. Consistent with this scenario is that primary cells obtained from nesprin-2 giant knockout mice show increased nuclear sizes and severely misshapen nuclei . Intriguingly, the expression of nesprin-2 giant isoforms, that exclusively lack the bulk of the ABD (Nesprin-2ΔABD) and which still contain the remainder of the molecule, rescue the NE deformation phenotype, but cannot reverse the increased nuclear area defects of nesprin-2 giant null cells. This result therefore in particular underlines the role of the ABD in nuclear shape regulation.
In conclusion, apart from its involvement in actin-mediated nuclear movement , the nesprin-2 ABD harbors additional functions in maintaining nuclear shape. Our assumption is that this is facilitated by interactions with nesprin-3 and possibly additional unknown associations with other NE constituents. Clearly, major important co-players are the cytoskeleton and the motor protein apparatus, elements to which nesprins have tight associations and which are concomitantly well-known nuclear shape regulators [36, 62]. Although nesprin-2 mini lacks a major microtubule-associating domain (i.e. kinesin light chain 1 binding site ), and while its expression does not yield obvious peri-nuclear cytoskeleton rearrangements in keratinocytes (contrary to what has been reported in COS7 cells ), our data show that nesprin-2 mini positive nuclei are integrated and subject to opposing cytoskeleton-associated forces. While chemically induced F-actin depolymerization further shrinks nuclei, microtubule disruption leads to nuclear expansion. These findings are consistent with current reports [36, 63] that indicate that nuclei are under a pre-stressed state, whereby actomyosin complexes apply outward pulling forces while microtubule-based structures exert compressing actions. Altogether, this illustrates that nuclear shape is the net outcome of complex intrinsic and extrinsic interactions that include integral NE constituents themselves (e.g., nesprins), as well as structures on the opposing sites of the nuclear membranes, such as the nuclear lamina, the genome, and the cytoskeleton [36, 62–65].
Considering the pronounced SUN and KASH-domain protein oligomerization properties, one can assume that such associations may jointly organize these molecules into larger complexes. In fact, nesprin molecules themselves may contribute to an expansion and the formation of even larger macromolecular complexes. Nesprin-1 was shown to oligomerize with itself, through its N- and C-terminal spectrin repeats [66, 67]. Also, nesprin-3 oligomerizes with itself, through its N-terminal spectrin repeats . Furthermore, SUN proteins form immobile macromolecular and promiscuous assemblies [20, 68] at the NE that may provide multiple docking sites for both N- and C-terminal nesprin ends. As a consequence, nesprins in conjunction with the cytoskeleton may form a multifunctional 3-D meshwork of filaments that encapsulates the ONM.
We thank Drs Arto Maatta and Arnoud Sonnenberg for providing reagents and Drs. Patrick Hussey, Andrei Smertenko, and Roy Quinlan for valuable discussions. We are also grateful to Dr. Tim Hawkins for excellent advice on confocal microscopy. This work was supported by the Deutsche Forschungsgemeinschaft (DFG; KA 2778/1-1) and a Wellcome Trust “Value in People” award to I.K.. W.L., and S.T. were members of the NRW International Graduate School in Development and Disease (IGSDHD), Cologne.